| Literature DB >> 11057775 |
H Yagi1, M Igawa, H Shiina, K Shigeno.
Abstract
We describe a case of an HTLV-1 carrier who developed bladder cancer and neurogenic bladder. HTLV-1 is thought to alter host immune function and to contribute to the development of other malignancies. It is also sometimes reported that urinary symptoms precede pyramidal symptoms in patients with HAM. To our knowledge, concomitant presence of bladder cancer and neurogenic bladder in an HTLV-1 carrier has not been previously reported.Entities:
Mesh:
Year: 2000 PMID: 11057775 DOI: 10.1023/a:1007104117250
Source DB: PubMed Journal: Int Urol Nephrol ISSN: 0301-1623 Impact factor: 2.266